BMD003 (CFTR mRNA)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMD003 (CFTR mRNA), covering 2026-03-20 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Inhaled BMD003 (CFTR mRNA) in Chinese Cystic Fibrosis Patients Aged ≥12 Years [EARLY_Phase 1]